The Patent Finder

Entopharm Co., Ltd.

Also on record
Records under this name other than patents Entopharm Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Entopharm Co., Ltd.

PatentTitleStatus Expires Confidence
US 7,462,360Alloferons—immunomodulatory peptides
Formerly held
Term ended
Term ended Jul 13, 2022 · From the USPTO record
Term endedTerm ended Jul 13, 2022From the USPTO record
US 6,692,747Alloferons—immunomodulatory peptides
Formerly held
Term ended
Term ended Dec 27, 2020 · From the USPTO record
Term endedTerm ended Dec 27, 2020From the USPTO record
US 6,337,093Immunomodulatory and antimicrobial materials, their preparation and use
Formerly held
Term ended
Term ended Dec 2, 2019 · From the USPTO record
Term endedTerm ended Dec 2, 2019From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited